DISCLAIMER
The information and materials accessed through or made available for use on any of our Sites, including, any information about diseases, conditions, treatments, or medicines, are for informational purposes only. The Content is not intended to be and is not a substitute for professional medical advice, diagnosis, or treatment, and your participation on our Sites does not create a healthcare professional-patient relationship. You should consult a doctor or other qualified health care professional regarding any questions you have about your health or before making any decisions related to your health or wellness. Call your doctor or 911 immediately if you think you may have a medical emergency.message sent
email sent successfully
rareLife solutions 606 Post Road East #397 Westport, CT 06880 |
||
You are receiving this because you have an account on www.oneAMYLOIDOSISvoice.com | ||
To unsubscribe from these emails, click here |
Trusted Resources: Community Center
Online support, community stories, financial assistance
Living With hATTR Amyloidosis: CeCe’s Story
For several years, CeCe was living with mysterious health challenges. After seeing numerous specialists and being misdiagnosed multiple times, CeCe finally found out she had hereditary ATTR (hATTR) amyloidosis, a rare, genetic disorder caused by the buildup of an abnormal protein that often affects the heart, nerves, and GI systems. This journey started many years ago, when CeCe was 55.
“I started having carpal tunnel syndrome in both hands,” she says. “I would wake up in the middle of the night with extreme pain. The muscles and nerves in my hands and wrists would suddenly start burning and stinging with hot, cutting pain radiating up both arms. The pain was horrible, and I cried many nights.”
Related Content
-
videos & visualsWild-Type Transthyretin Cardiac Amyloidosis – Mayo Clinichttps://www.youtube.com/watch?v=RnWxzRD1...
-
videos & visualsSteroids – ASG Webinar 4/13https://www.youtube.com/watch?v=4gUXPbOk...
-
educationExpert Consensus on Multidisciplinary Care for Cardiac Amyloidosis: 2023 ACC ReportThe American College of Cardiology (ACC)...
-
educationHereditary ATTR Val122Ile Cardiac AmyloidosisHereditary ATTR amyloidosis is an inheri...
-
people & placesUniversity of Arkansas for Medical Sciences Myeloma CenterUniversity of Arkansas for Medical Scien...
-
videos & visualsNovel Agents for the Treatment of AL Amyloidosis: Dr. Tibor Kovacsovics – ASG Webinar 3/13https://www.youtube.com/watch?v=NrEjyVeJ...
-
educationA Prospective Phase 2 Trial of Daratumumab in Patients With Previously Treated Systemic Light-Chain AmyloidosisDaratumumab is a human monoclonal anti...
send a message
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.